Most Isoflavones source from high-quality non-GMO soybeans in Heilongjiang province. Originated in developed countries such as Japan, Europe and America, Isoflavones, as herbal estrogen, are proven to decrease the risk of cancers, heart diseases and osteoporosis, and improve climacteric symptom.
Most consumers don't know whether the isoflavones they eat are absorbed. There are two kinds of isoflavones, aglycone isoflavone(active) and glucoside isoflavone(non-active). Most supplements contain glucoside isoflavone rather than aglycone isoflavone, which means that the nutrition can't be absorbed. Based on original isoflavones, the newly developed free isoflavones have applied for patent. Featured by aglycone isoflavone, the patented one primarily contains more active genistein, daidzein and glycitin. The refined one can resist heat and gastric acid. Therefore, the new product is easier to be absorbed into stomach and intestines. It's an potential product, according to Xiamen Allycare Biotech.
Copyright：Herbridge Media
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
